1. Home
  2. HALO vs AN Comparison

HALO vs AN Comparison

Compare HALO & AN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • AN
  • Stock Information
  • Founded
  • HALO 1998
  • AN 1991
  • Country
  • HALO United States
  • AN United States
  • Employees
  • HALO N/A
  • AN N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • AN Other Specialty Stores
  • Sector
  • HALO Health Care
  • AN Consumer Discretionary
  • Exchange
  • HALO Nasdaq
  • AN Nasdaq
  • Market Cap
  • HALO 7.6B
  • AN 8.3B
  • IPO Year
  • HALO N/A
  • AN N/A
  • Fundamental
  • Price
  • HALO $68.24
  • AN $193.23
  • Analyst Decision
  • HALO Buy
  • AN Strong Buy
  • Analyst Count
  • HALO 11
  • AN 10
  • Target Price
  • HALO $74.91
  • AN $226.10
  • AVG Volume (30 Days)
  • HALO 2.2M
  • AN 491.5K
  • Earning Date
  • HALO 11-03-2025
  • AN 10-23-2025
  • Dividend Yield
  • HALO N/A
  • AN N/A
  • EPS Growth
  • HALO 56.68
  • AN N/A
  • EPS
  • HALO 4.74
  • AN 16.99
  • Revenue
  • HALO $1,242,852,000.00
  • AN $27,915,400,000.00
  • Revenue This Year
  • HALO $32.47
  • AN $6.97
  • Revenue Next Year
  • HALO $24.31
  • AN $2.55
  • P/E Ratio
  • HALO $14.41
  • AN $11.36
  • Revenue Growth
  • HALO 31.19
  • AN 6.06
  • 52 Week Low
  • HALO $42.01
  • AN $148.33
  • 52 Week High
  • HALO $79.50
  • AN $228.92
  • Technical
  • Relative Strength Index (RSI)
  • HALO 56.09
  • AN 33.06
  • Support Level
  • HALO $67.40
  • AN $187.69
  • Resistance Level
  • HALO $66.97
  • AN $200.95
  • Average True Range (ATR)
  • HALO 2.04
  • AN 5.85
  • MACD
  • HALO 0.51
  • AN -1.15
  • Stochastic Oscillator
  • HALO 71.78
  • AN 15.95

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About AN AutoNation Inc.

AutoNation is the second-largest automotive dealer in the United States, with 2024 revenue of about $27 billion and over 240 dealerships, plus 52 collision centers. The firm also has 26 AutoNation USA used-vehicle stores, a captive lender, four auction sites, and three parts distributors across 20 states primarily in Sunbelt metropolitan areas. New-vehicle sales account for nearly half of revenue; the company also sells used vehicles, parts, and repair services as well as auto financing. The company (formerly Republic Industries) divested its waste management unit (Republic Services) in 1999 and its car rental businesses (ANC Rental) in 2000. Wayne Huizenga founded the company in the 1990s to bring the rollup acquisition strategy to auto retailing, which has proved to be a smart move.

Share on Social Networks: